EcoDrugPlus

Prostaglandin E Receptor 3

Ensembl ID : ENSVPAG00000002939
Gene Symbol: PTGER3
1 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSVPAG00000002540
Gene Symbol: PTGER4
1 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSVPAG00000010317
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSVPAG00000005815
Gene Symbol: PTGS2
1 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSVPAG00000008820
Gene Symbol: PSMA1
1 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSVPAG00000006820
Gene Symbol: PSMA2
1 Cross references
234 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSVPAG00000003643
Gene Symbol: PSMA3
1 Cross references
235 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSVPAG00000008257
Gene Symbol: PSMA4
3 Cross references
248 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSVPAG00000005590
Gene Symbol: PSMA5
1 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSVPAG00000005691
Gene Symbol: PSMA6
3 Cross references
279 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSVPAG00000011344
Gene Symbol: PSMA8
1 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSVPAG00000006517
Gene Symbol: PSMB1
1 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).